| Title | Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide. | | Author(s) | Pelavin PI, Abramson E, Pon S, Vogiatzi MG | | Institution | Department of Pediatrics, Valley Health System, The Valley Hospital, Ridgewood, NJ, USA. | | Source | J Pediatr Endocrinol Metab 2009 Feb; 22(2):171-5. | | MeSH | Child
Female
Gastrointestinal Agents
Glipizide
Glucose
Humans
Hyperinsulinism
Hypoglycemia
Hypoglycemic Agents
Injections, Subcutaneous
Octreotide
Overdose
Treatment Outcome
| | Abstract | The onset of symptomatic hypoglycemia in children with ingestions of second-generation sulfonylureas has never been documented to be later than 21 hours post-ingestion. We report a case with the longest known interval, 45 hours, between ingestion of a sulfonylurea and the onset of hypoglycemia requiring medical intervention. The hypoglycemia was severe and required multiple dextrose boluses in addition to continuous dextrose infusion for 36 hours. This patient was also treated with multiple doses of subcutaneous octreotide because of persistent hypoglycemia despite the above management. This case represents the first report of subcutaneous octreotide used as a treatment for pediatric hypoglycemia secondary to sulfonylurea exposure. | | Language | eng | | Pub Type(s) | Case Reports
Journal Article
Research Support, N.I.H., Extramural
| | PubMed ID | 19449674 |
|
